StockData
Harmony Biosciences Holdings, Inc. logo

Harmony Biosciences Holdings, Inc. (HRMY) stock

HRMYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 18/3039% below fair value
$33.11+0.10 (+0.30%)

Close on Nov 18, 2026Market cap $1.93BP/E 10.7Yield –

Earnings

Harmony Biosciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 23, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$268.90M
+12.3% on a year earlier
Adjusted EPS, Q3 FY2026
$0.81
$0.87 a year earlier
Latest guidance
Reaffirmed
Nov 4, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Harmony Biosciences's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 23, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 4, 2026before the open$268.90M+12.3%$0.81–Release
Q2 FY2026ended Jun 30, 2026Jul 16, 2026before the open$261.00M+30.2%––Release
Q1 FY2026ended Mar 31, 2026May 7, 2026before the open$215.40M+16.6%$0.55–Release
Q4 FY2025ended Dec 31, 2025Feb 24, 2026before the open$243.80M+21.1%$0.38$0.57Release
Q3 FY2025ended Sep 30, 2025Nov 4, 2025before the open$239.50M+28.8%$0.87–Release
Q2 FY2025ended Jun 30, 2025Aug 5, 2025before the open$200.50M+16.0%$0.68$0.92Release
Q1 FY2025ended Mar 31, 2025May 6, 2025before the open$184.70M+19.5%$0.78$1.03Release
Q4 FY2024ended Dec 31, 2024Feb 25, 2025before the open$201.30M+19.5%$0.85$1.08Release
Q3 FY2024ended Sep 30, 2024Oct 29, 2024before the open$186.00M+16.0%$0.79–Release
Q2 FY2024ended Jun 30, 2024Aug 6, 2024before the open$172.80M+28.8%$0.20$1.05Release
Q1 FY2024ended Mar 31, 2024Apr 30, 2024before the open$154.60M+29.8%–$0.88Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Harmony Biosciences's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
net product revenueFY2026$1.00B – $1.04B$1.00B – $1.04BReaffirmedJul 16, 2026
net revenueFY2026$1.00B – $1.04B$1.00B – $1.04BReaffirmedNov 4, 2026

Guidance vs results

The last range Harmony Biosciences gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Revenue$845.00M – $865.00M$868.50MΣ4QAbove range

Guidance history

Every forecast Harmony Biosciences put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 4, 2026net revenueFY2026$1.00B – $1.04BReaffirmed
Jul 16, 2026net product revenueFY2026$1.00B – $1.04BReaffirmed
May 7, 2026Net revenueFY2026$1.00B – $1.04BReaffirmed
Feb 24, 2026Net revenueFY2026$1.00B – $1.04BNew
Jan 12, 2026Net revenueFY2026$1.00B – $1.04BNew
Nov 4, 2025net product revenueFY2025$845.00M – $865.00MRaised
Oct 23, 2025revenue guidanceFY2025$845.00M – $865.00MNew
Aug 5, 2025net product revenueFY2025$820.00M – $860.00MReaffirmed
May 6, 2025net product revenueFY2025$820.00M – $860.00MReaffirmed
Feb 25, 2025net product revenueFY2025$820.00M – $860.00MReaffirmed
Jan 13, 2025Net revenueFY2025$820.00M – $860.00MNew
Oct 29, 2024net product revenueFY2024$700.00M – $720.00MReaffirmed
Aug 6, 2024net product revenueFY2024$700.00M – $720.00MReaffirmed
Apr 30, 2024net product revenueFY2024$700.00M – $720.00MNew
Feb 22, 2024net product revenueFY2024$700.00M – $720.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Harmony Biosciences filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Update
  4. Results
  5. Results
  6. Results
  7. Results
  8. Results
  9. Update
  10. Update
  11. Results
  12. Results
  13. Results
  14. Results
  15. Results

See a number that looks wrong?